Phio Pharmaceuticals (PHIO) Price to Sales (2012 - 2019)

Phio Pharmaceuticals (PHIO) has reported Price to Sales for 8 consecutive years, with 27564.36 the latest figure, recorded in Q1 2019.

• For the quarter ending Q1 2019, Price to Sales rose 32.6% year-over-year to 27564.36; the trailing twelve-month figure through Dec 2019 stood at 206.39 (down 77.72% YoY), and the FY2019 full-year result was 206.39, down 77.72% from the prior year.
• Price to Sales climbed to 27564.36 in Q1 2019 per PHIO's latest filing, from 5023.49 in the prior quarter.
• Across five years, Price to Sales topped out at 97029.9 in Q1 2016 and bottomed at 5023.49 in Q3 2018.
• Historically, Price to Sales has averaged 41428.64 across 5 years, with a median of 27618.88 in 2015.
• The sharpest annual moves came in 2015 and 2016: Price to Sales plunged 74.54% in 2015, then jumped 250.62% in 2016.
• Over 5 years, Price to Sales stood at 27673.41 in 2015, then jumped by 246.3% to 95832.0 in 2016, then tumbled by 48.31% to 49537.4 in 2017, then tumbled by 89.86% to 5023.49 in 2018, then jumped by 448.71% to 27564.36 in 2019.
• According to Business Quant data, Price to Sales over the past three periods registered 27564.36, 5023.49, and 7980.27 for Q1 2019, Q3 2018, and Q2 2018 respectively.